Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose

Lancet. 2022 Feb 12;399(10325):625-626. doi: 10.1016/S0140-6736(22)00090-3. Epub 2022 Jan 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • 2019-nCoV Vaccine mRNA-1273 / administration & dosage*
  • 2019-nCoV Vaccine mRNA-1273 / immunology
  • Adult
  • BNT162 Vaccine / administration & dosage*
  • BNT162 Vaccine / immunology
  • COVID-19 / epidemiology*
  • COVID-19 / immunology
  • COVID-19 / prevention & control
  • COVID-19 / virology
  • COVID-19 Vaccines / immunology
  • ChAdOx1 nCoV-19 / administration & dosage*
  • ChAdOx1 nCoV-19 / immunology
  • Female
  • Humans
  • Immunization, Secondary
  • Immunogenicity, Vaccine
  • Male
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / isolation & purification
  • SARS-CoV-2 / pathogenicity*
  • Viral Load

Substances

  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19
  • 2019-nCoV Vaccine mRNA-1273
  • BNT162 Vaccine

Supplementary concepts

  • COVID-19 breakthrough infections
  • SARS-CoV-2 variants